p38 MAPK inhibitor. Supresses p38 phosphorylation and LPS-induced TNF-α
production in macrophages and in vivo
. Attenuates zymosan-induced inflammation and adjuvant-induced arthritis in murine models. Orally active.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
DBM1285 suppresses tumor necrosis factor α production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang et al.